Parexel Intl Cp (PRXL) 68.70 $PRXL IMPORTANT INVESTOR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Parexel Intl Cp (PRXL) 68.70 $PRXL

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of PAREXEL International Corporation
BusinessWire - Thu Sep 01, 11:02AM CDT
Khang & Khang LLP (the "Firm" announces that it is investigating claims against PAREXEL International Corporation ("PAREXEL" or the "Company" (Nasdaq: PRXL) concerning possible violations of federal securities laws.
PRXL: 68.70 (+0.36)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PAREXEL International Corporation (PRXL)
ACCESSWIRE - Thu Sep 01, 9:02AM CDT
NEW YORK, NY / ACCESSWIRE / September 1, 2016 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities PAREXEL International Corporation ("PARXEL" or the "Company" (NASDAQ: PRXL). Such investors are advised to contact Peretz Bronstein or his investor relations analyst, Yael Hurwitz at info@bgandg.com or 212-697-6484.
PRXL: 68.70 (+0.36)

PAREXEL International to Present at Wells Fargo Healthcare Conference
BusinessWire - Thu Sep 01, 8:30AM CDT
PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Wells Fargo Healthcare Conference on Wednesday September 7, 2016 in Boston. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 9:20a.m. ET.
PRXL: 68.70 (+0.36), WFC: 50.55 (+0.12)

SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of PAREXEL International Corporation and Advises Investors With Losses to Contact the Firm
BusinessWire - Wed Aug 31, 6:41PM CDT
Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against PAREXEL International Corporation ("PAREXEL" or the "Company" (Nasdaq: PRXL) concerning possible violations of federal securities laws.
PRXL: 68.70 (+0.36)

INVESTOR ALERT: Investigation of PAREXEL International Corporation Announced by Law Offices of Howard G. Smith
BusinessWire - Wed Aug 31, 5:45PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of PAREXEL International Corporation ("PAREXEL" or the "Company" (NASDAQ: PRXL) concerning the Company and its officers' possible violations of federal securities laws.
PRXL: 68.70 (+0.36)

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against PAREXEL International Corporation and Advises Investors With Losses to Contact the Firm
BusinessWire - Wed Aug 31, 4:58PM CDT
Goldberg Law PC announces that it is investigating PAREXEL International Corporation ("PAREXEL" or the "Company" (Nasdaq: PRXL) concerning possible violations of federal securities laws.
PRXL: 68.70 (+0.36)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of PAREXEL International Corporation
BusinessWire - Wed Aug 31, 4:08PM CDT
Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ RXL) ("PAREXEL" concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
PRXL: 68.70 (+0.36)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of PAREXEL Corporation - PRXL
PR Newswire - Wed Aug 31, 3:46PM CDT
Pomerantz LLP is investigating claims on behalf of investors of PAREXEL Corporation ("PAREXEL" or the "Company" (NASDAQ: PRXL). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
PRXL: 68.70 (+0.36)

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against PAREXEL International Corporation - PRXL
BusinessWire - Wed Aug 31, 2:27PM CDT
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ RXL) resulting from allegations that PAREXEL may have issued materially misleading business information to the investing public.
PRXL: 68.70 (+0.36)

SmarTrend Watching for Potential Pullback in Shares of Parexel International After 2.14% Gain
Comtex SmarTrend(R) - Mon Aug 29, 4:22PM CDT
Parexel International (NASDAQ RXL) traded in a range yesterday that spanned from a low of $68.80 to a high of $70.24. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $69.98 on volume of 178,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRXL: 68.70 (+0.36)

PAREXEL's Head of BioPharm Unit Named to the 2016 PharmaVOICE 100
BusinessWire - Mon Aug 15, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that PharmaVOICE magazine selected Ubavka DeNoble, MD, Corporate Vice President, as one of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2016 issue of PharmaVOICE, recognizes Dr. DeNoble for her innovative thinking, passion and fervor for the industry, and dedication to mentoring the next generation of leaders.
PRXL: 68.70 (+0.36)

PAREXEL International (PRXL) Q4 Earnings Beat, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:12AM CDT
PAREXEL International (PRXL) reported fourth-quarter fiscal 2016 adjusted earnings per share of 94 cents.
PRXL: 68.70 (+0.36), ABCO: 42.22 (+0.04), HQY: 33.55 (+1.05), PRAH: 50.38 (-0.18)

PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
BusinessWire - Wed Aug 03, 3:27PM CDT
--GAAP diluted earnings per share of $0.83, up 36.1%; adjusted earnings per share of $0.94, up 19.0%
PRXL: 68.70 (+0.36)

Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:36AM CDT
The Medical sector is expected to deliver 5.4% earnings growth on 10.5% higher revenues in the second quarter.
PRXL: 68.70 (+0.36), EVHC: 22.18 (+0.73), CRL: 84.42 (+0.82), HUM: 177.33 (+0.80)

PAREXEL Appoints Four Executives to Senior Leadership Team
BusinessWire - Mon Aug 01, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company executives to its senior-most leadership team, the Business Review Committee:
PRXL: 68.70 (+0.36)

PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
BusinessWire - Mon Jun 20, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia.
PRXL: 68.70 (+0.36)

PAREXEL Invites Public to Listen to Live Webcast of Investor Day Presentations on June 30
BusinessWire - Wed Jun 15, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from 9:00 a.m. to 12:00 p.m. EDT.
PRXL: 68.70 (+0.36)

PAREXEL Announces Master Services Agreement with Pfizer
BusinessWire - Fri Jun 10, 1:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed.
PRXL: 68.70 (+0.36)

PAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American Business Awards
BusinessWire - Thu Jun 02, 8:00AM CDT
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year - Pharmaceuticals in the 14th Annual American Business Awards(SM). The judges awarded PAREXEL a Gold Stevie(R) Award and recognized the Company's investments in innovation and expanded capabilities across the drug development continuum in 2015 as specifics for the accolade.
PRXL: 68.70 (+0.36)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 99

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 27

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 235

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 335

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 254

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 148

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 489

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Albion KAY VCT PLC's Strong Half-Year Performance Review

Updated Category News Views 95

Overview of Albion KAY VCT PLC Albion KAY VCT PLC plays a critical role in the investment landscape. The Company has recently published its Half-yearly Financial Report, which has garnered significant interest from both shareholders and potential investors. This report provides an in-depth look at the Company’s operations and financial condition over the six months...

Continue Reading
BlackRock Inc. Acknowledges Significant Stake in Syensqo

Updated Category News Views 160

Participation Notification by BlackRock Inc. In a recent communication, BlackRock Inc. has informed Syensqo of their increase in voting rights ownership, surpassing the critical threshold of 3%. This change is attributed to recent acquisitions or disposals of voting securities, which is in line with European transparency regulations. Details of the Notification The...

Continue Reading
Black Kite Unveils Innovative Global AI Risk Assessment Nexus

Updated Category News Views 204

Black Kite Launches Groundbreaking AI Assessment Framework Black Kite's GA³™ framework addresses a significant void in current global assurance frameworks. It creates a comprehensive standard that adapts to the ever-changing AI threat landscape. Importance of AI Risk Management Frameworks As cyber threats evolve, organizations face challenges in third-party risk...

Continue Reading
Purdue University Leads All-Boilermaker Mission with Virgin Galactic

Updated Category News Views 255

Purdue University Embarks on a Landmark Space Mission Building upon its rich legacy in space exploration, Purdue University is poised to undertake a remarkable journey — an all-Boilermaker crew will participate in a Virgin Galactic suborbital spaceflight known as Purdue 1. Set to launch in the near future, this mission opens up new avenues for academic exploration in...

Continue Reading
LP Building Solutions Provides Update on Q3 2024 Earnings Call

Updated Category News Views 77

LP Building Solutions Reveals Q3 2024 Earnings Call Details LP Building Solutions (NYSE: LPX), a prominent player in the building materials sector, has officially announced the schedule for its earnings conference call, set for an upcoming Tuesday. This anticipated event will highlight the financial results for the third quarter of 2024. Important Conference Call...

Continue Reading